Artificial intelligence - Machine Learning Izotropic needs to consider incorporating machine learning/artificial intelligence into their imaging product.
Artificial intelligence is the future. We are in huge shortage of radiologists/ professionals that can interpret the imaging data. It is paramount to spot cancer at the earliest stage possible, as it allows the highest chance of recovery. Machine learning/ AI -- can allow non-imaging professionals, such as nurses, to have a relatively high confidence in spotting early onset of cancer.
In addition, Artificial intelligence/machine learning is a huge hype at the moment, simply mentioning it in your medical company may boost perceived value, thus attracting potential investors. This is exactly what Izotropic needs right now, as it needs to survive the oncoming years of cashflow expenses.